# Institut de Cancérologie de Bourgogne

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/institut-de-cancerologie-de-bourgogne/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 78 |
| Citations | 4,911 |
| City | Auxerre |
| Country | France |
| Description | Institut de Cancérologie de Bourgogne is a research organisation in Auxerre, France. OpenAlex records 408 works and 4,911 citations for it. 1 researchers list it as their most recent affiliation. |
| Homepage | http://institut-cancerologie-bourgogne.fr/ |
| OpenAlex ID | https://openalex.org/I4210112591 |
| Researchers | 1 |
| ROR ID | https://ror.org/02ak4m037 |
| Type | healthcare |
| Works | 408 |

## University papers

- [Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma](https://scholariq.org/papers/lenalidomide-bortezomib-and-dexamethasone-with-transplantation-for-myeloma/)
- [Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study](https://scholariq.org/papers/bortezomib-thalidomide-and-dexamethasone-with-or-without-daratumumab-before-and/)
- [Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies](https://scholariq.org/papers/liposomal-amphotericin-b-in-combination-with-caspofungin-for-invasive/)
- [Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial](https://scholariq.org/papers/maintenance-with-daratumumab-or-observation-following-treatment-with-bortezomib/)

## University researchers

- [Denis Caillot](https://scholariq.org/researchers/denis-caillot/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.